These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26069187)

  • 21. Nivolumab: targeting PD-1 to bolster antitumor immunity.
    Brahmer JR; Hammers H; Lipson EJ
    Future Oncol; 2015; 11(9):1307-26. PubMed ID: 25798726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trastuzumab trials steal show at ASCO meeting.
    Tuma RS
    J Natl Cancer Inst; 2005 Jun; 97(12):870-1. PubMed ID: 15956644
    [No Abstract]   [Full Text] [Related]  

  • 23. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS
    J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
    [No Abstract]   [Full Text] [Related]  

  • 24. New therapeutic options in systemic treatment of advanced cutaneous melanoma.
    Mackiewicz-Wysocka M; Zolnierek J; Wysocki PJ
    Expert Opin Investig Drugs; 2013 Feb; 22(2):181-90. PubMed ID: 23215674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy of Melanoma.
    Snyder A; Zamarin D; Wolchok JD
    Prog Tumor Res; 2015; 42():22-9. PubMed ID: 26376963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 27. Vemurafenib for the treatment of BRAF mutant metastatic melanoma.
    Martin-Liberal J; Larkin J
    Future Oncol; 2015; 11(4):579-89. PubMed ID: 25686114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.
    Melnikova VO; Bar-Eli M
    Pigment Cell Res; 2006 Oct; 19(5):395-405. PubMed ID: 16965268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical development of the anti-CTLA-4 antibody tremelimumab.
    Ribas A
    Semin Oncol; 2010 Oct; 37(5):450-4. PubMed ID: 21074059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ipilimumab for advanced melanoma: let's not throw caution to the winds.
    Lowe M; Delman KA
    Oncology (Williston Park); 2010 Dec; 24(14):1296, 1299. PubMed ID: 21294473
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunotherapies and melanoma].
    Routier É; Robert C; Mateus C
    Bull Cancer; 2014 Dec; 101 Suppl 2():S13-24. PubMed ID: 25776763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy for advanced melanoma.
    Roman RA
    Clin J Oncol Nurs; 2011 Oct; 15(5):E58-65. PubMed ID: 21951748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment for metastatic malignant melanoma: old drugs and new strategies.
    Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
    Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ipilimub for advanced melanoma].
    Kiyohara Y
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):439-42. PubMed ID: 26020985
    [No Abstract]   [Full Text] [Related]  

  • 35. [New breakthroughs in Oncodermatology].
    Mortier L
    Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S158-64. PubMed ID: 21193119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is there progress in chemotherapy for breast cancer?].
    Wenzel C; Schmidinger M; Huber H
    Wien Klin Wochenschr; 2001 Apr; 113(9):306-20. PubMed ID: 11388076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On newer treatments for lymphoma.
    Oncology (Williston Park); 2000 Jun; 14(6):794-6. PubMed ID: 10887630
    [No Abstract]   [Full Text] [Related]  

  • 38. Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011.
    Luke JJ; Rubinstein LV; Smith GL; Ivy SP; Harris PJ
    Melanoma Res; 2013 Apr; 23(2):152-8. PubMed ID: 23411478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What's new in dermatological treatments?].
    Martin L
    Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S165-76. PubMed ID: 21193120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ofatumumab and its role as immunotherapy in chronic lymphocytic leukemia.
    Sandhu S; Mulligan SP
    Haematologica; 2015 Apr; 100(4):411-4. PubMed ID: 25828085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.